Radiation Oncology, the First Hospital of China Medical University, Shenyang, China.
Department of Radiation Oncology, the First Hospital of China Medical University, Shenyang, China.
Cancer Med. 2021 Nov;10(22):8079-8090. doi: 10.1002/cam4.4327. Epub 2021 Oct 14.
Metastatic upper urinary tract urothelial carcinoma (mUTUC) is a relatively rare urothelial carcinoma, and little attention has been given to it. Our study established a nomogram by analyzing the prognostic factors of mUTUC to predict the survival of patients and revealed that the role of surgery at the primary tumor site. We extracted our data (2010-2016) from the Surveillance, Epidemiology, and End Results (SEER) database, and 628 patients with distant metastasis were identified. Propensity score matching (PSM) was used to balance the clinical variable bias in a 1:1 ratio. After PSM, we enrolled 502 patients in our study cohort. Univariate and multivariate Cox regression analyses and Kaplan-Meier curves showed that T stage, N stage, hepatic metastasis, surgery, and chemotherapy were prognostic factors for mUTUC before and after PSM. Based on the findings, a nomogram was constructed to predict the 12-month survival of patients with distant metastasis. The analysis of subgroups of T stage, N stage, and different metastatic sites demonstrated that the survival of patients with T1/T2, N0/N1/N2/N3, metastasis including liver, and metastasis including bone could be improved by a combination of surgery and chemotherapy, while for the patients with T3/T4/TX, NX, metastasis including lung, and metastasis including distant lymph nodes, chemotherapy alone was a better choice to improve their overall survival. Radiotherapy has been proven to be useful for patients with N1/N2/N3 stage. We have provided more precise treatment strategies for stage IV patients. Our research fully affirms the role of surgery on primary site in UTUC patients with distant metastasis and the significance of classifying the patients into subgroups by integrating variables including T stage, N stage, and different metastatic sites to select the optimal treatment method.
转移性上尿路上皮癌(mUTUC)是一种相对罕见的尿路上皮癌,其关注度较低。我们通过分析 mUTUC 的预后因素建立了一个列线图,以预测患者的生存情况,并揭示了原发肿瘤部位手术的作用。我们从监测、流行病学和最终结果(SEER)数据库中提取了我们的数据(2010-2016 年),并确定了 628 例远处转移的患者。采用倾向评分匹配(PSM)以 1:1 的比例平衡临床变量偏倚。PSM 后,我们将 502 例患者纳入我们的研究队列。单变量和多变量 Cox 回归分析和 Kaplan-Meier 曲线显示,T 分期、N 分期、肝转移、手术和化疗是 mUTUC 的预后因素,无论是在 PSM 之前还是之后。基于这些发现,构建了一个列线图来预测远处转移患者的 12 个月生存率。对 T 分期、N 分期和不同转移部位亚组的分析表明,T1/T2、N0/N1/N2/N3、包括肝脏在内的转移以及包括骨骼在内的转移的患者,手术联合化疗可以提高生存率,而 T3/T4/TX、NX、包括肺部在内的转移以及包括远处淋巴结在内的转移的患者,单独化疗是改善总体生存率的更好选择。放疗已被证明对 N1/N2/N3 期患者有效。我们为 IV 期患者提供了更精确的治疗策略。我们的研究充分肯定了手术在 mUTUC 远处转移患者中的原发部位的作用,以及通过整合 T 分期、N 分期和不同转移部位等变量将患者分为亚组,选择最佳治疗方法的重要性。